| Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India A Gupta, N Desai, Sanjeev, P Chauhan, S Nityanand, Z Hashim, M Gupta Annals of Hematology, 1-11, 2022 | 13 | 2022 |
| The GLAMM1 Study-Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally R Atallah, Y Shatnawi, A Mammadzadeh, SK Hashmi, R Shabeeha, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2024 | 1 | 2024 |
| The GLAMM1 Study-Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally R Atallah, Y Shatnawi, A Mammadzadeh, SK Hashmi, SK Rana, ... Blood 142, 3327, 2023 | 1 | 2023 |
| Inequalities in the career pathway for paediatric HSCT and cellular therapy physicians C Gurnari, M Spadea, R Muratori, V Jimenez, V Radici, S Torrado, ... The Lancet Haematology 10 (7), e492-e494, 2023 | 1 | 2023 |
| Outbreak of Ralstonia mannitolilytica Infection in Hemato-Oncology Unit: Case Series and Review of Literature P Chauhan, A Gupta, C Sahu, N Desai, S Nityanand Indian Journal of Medical and Paediatric Oncology 43 (02), 201-207, 2022 | 1 | 2022 |
| COVID-19 in children with hematological disorders–Outcomes, impact on management, and the way forward N Desai, A Gupta, P Mehta Cancer Research, Statistics, and Treatment 4 (3), 589-590, 2021 | 1 | 2021 |
| Precursor B Cell Acute Lymphoblastic Leukemia Presenting with Repeated Episodes of Hemophagocytic Lymphohistiocytosis N Desai, D Chandra, R Gupta, R Kashyap Indian Journal of Medical and Paediatric Oncology, 2024 | | 2024 |
| Hemophagocytic Lymphohistiocytosis: A Rare Complication of Acute Hepatitis E Infection N Desai, D Vetal, A Kulkarni, N Karnik, T Trivedi The Journal of the Association of Physicians of India 72 (4), 91-93, 2024 | | 2024 |
| Late‐onset Pneumocystis jirovecii pneumonia post‐allogeneic stem cell transplantation after time‐dependent discontinuation of prophylaxis V Stavi, N Desai, FV Michelis, DDH Kim, R Kumar, JH Lipton, AD Law European Journal of Haematology 112 (3), 433-438, 2024 | | 2024 |
| Bleeding Diathesis Secondary to a Heparin-Like Anticoagulant in a Patient with Multiple Myeloma—A Case Report and Review of Literature N Desai, S Biswas, D Chandra, R Gupta, A Gupta, R Kashyap Indian Journal of Medical and Paediatric Oncology 45 (01), 087-091, 2024 | | 2024 |
| Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant A Mammadzadeh, Y Shatnawi, R Atallah, B Mohamed, N Desai, ... Blood 142 (Supplement 1), 4727-4727, 2023 | | 2023 |
| PB1863: VENETOCLAX AND HYPOMETHYLATING AGENT BASED OUTPATIENT AML INDUCTION-COST-EFFECTIVE METHOD FOR LMICS-REAL WORLD DATA FROM A TERTIARY CARE CENTER P Chauhan, N Desai, S Agarwal, A Pandharipande, S Yadav, A Gupta, ... HemaSphere 7 (S3), e5927047, 2023 | | 2023 |
| Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience N Desai, I Pasic, AD Law, W Lam, A Gerbitz, A Viswabandya, DD Kim, ... European Journal of Haematology, 0 | | |
Al-Ola AbdallahKUMCDirección de correo verificada de kumc.edu